Holen Sie sich die Stockscreener-App
2.68
3.25%
-0.09
Entera Bio Ltd Aktie (ENTX) Neueste Nachrichten
Form PRE 14A ENTERA BIO LTD. For: 27 September By Investing.com - Investing.com Australia
Form PRE 14A ENTERA BIO LTD. For: 27 September By Investing.com - Investing.com Nigeria
After raising about $275 million, Entera Bio (ENTX) asks shareholders to expand its share incentive plan. - Stock Titan
Entera Bio (Nasdaq:ENTX)Stock Analysis - Simply Wall Street
Entera Bio Stock Price Forecast. Should You Buy ENTX? - StockInvest.us
Entera Bio Ltd. WarrantADR (ENTXW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Entera Bio Ltd. WarrantADR (ENTXW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Entera Bio Ltd. WarrantADR (ENTXW) Peer Comparison – Compare with Others - Value Research
Entera Bio Ltd. SEC Filing (Aug 31, 2026) - Stock Titan
Entera to Participate in Upcoming Fall Investor Conferences - Yahoo Finance
Entera (ENTX) Earnings Reading: Reported EPS Misses Expectations on the Day; Stock Move: Shares Move Higher 5.88%Quarterly Profit Report - vinanet.vn
Entera (ENTX) Earnings Reading: Reported EPS Misses Expectations on the Day; Stock Move: Shares Move Higher 5.88%Pre-Earnings Drift - dars.gov.et
Entera (ENTX) Earnings Reading: Reported EPS Misses Expectations on the Day; Stock Move: Shares Move Higher 5.88%SaaS Earnings Trends - careplusvn.com
Entera (ENTX) Earnings Reading: Reported EPS Misses Expectations on the Day; Stock Move: Shares Move Higher 5.88%Basic EPS Analysis - dars.gov.et
Entera (ENTX) Earnings Reading: Reported EPS Misses Expectations on the Day; Stock Move: Shares Move Higher 5.88%Earnings Cycle Outlook - dars.gov.et
Entera Bio (NASDAQ:ENTX) Stock Price Up 5.1%Here's Why - MarketBeat
Entera (ENTX) Earnings Snapshot: Profit Per Share Falls Below Its Benchmark in the Reported Period - vinanet.vn
Entera (ENTX) Earnings Snapshot: Profit Per Share Falls Below Its Benchmark in the Reported Period - careplusvn.com
Entera (ENTX) Earnings Snapshot: Profit Per Share Falls Below Its Benchmark in the Reported Period - dars.gov.et
Entera (ENTX) Results Review: EPS Misses Its Estimate; Market Move: Shares Finish 4.84% Up in the Current Update - vinanet.vn
Entera Bio appoints new chief medical officer - The Globe and Mail
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation - Sahm
symbol__ Stock Quote Price and Forecast - CNN
Entera Bio appoints Riccardo Camisasca as chief medical officer - Investing.com
Entera Bio appoints new chief medical officer - TipRanks
Entera Bio Names New Chief Medical Officer Ahead of EB613 Phase 3 Start - Minichart
Form 8K Entera Bio Ltd. For: 18 August By Investing.com - Investing.com Nigeria
Entera Bio appoints Riccardo Camisasca as chief medical officer By Investing.com - Investing.com Canada
Entera Bio appoints Riccardo Camisasca as chief medical officer By Investing.com - Investing.com UK
Form 8K Entera Bio Ltd. For: 18 August By Investing.com - Investing.com India
Form 8K Entera Bio Ltd. For: 18 August By Investing.com - Investing.com UK
A drug developer with 30-plus years joins Entera for a planned osteoporosis Phase 3 trial - Stock Titan
Renaissance Technologies LLC Buys 365,441 Shares of Entera Bio Ltd. $ENTX - MarketBeat
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo - GlobeNewswire
Entera Bio Eyes Phase 3 Start for Oral Osteoporosis Drug EB613 After FDA Agreement - MarketBeat
Entera Bio Eyes Phase 3 Start for Oral Osteoporosis Drug EB613 After FDA Agreement - Yahoo Finance
Short Interest in Entera Bio Ltd. (NASDAQ:ENTX) Increases By 286.7% - MarketBeat
Entera Bio at Canaccord Genuity: oral osteoporosis push advances By Investing.com - Investing.com Canada
Entera Bio (ENTX) completes $275M Rule 506(b) private offering of shares and warrants - Stock Titan
Entera Bio Ltd (ENTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Entera Bio shares slip as Q2 loss comes in wider than expected - Yahoo Finance
Entera Bio misses Q2 estimates, reports wider loss By Investing.com - Investing.com Nigeria
Entera Bio misses Q2 estimates, reports wider loss By Investing.com - Investing.com South Africa
Entera Bio misses Q2 estimates, reports wider loss By Investing.com - Investing.com Australia
Entera Bio misses Q2 estimates, reports wider loss By Investing.com - Investing.com India
Entera Bio misses Q2 estimates, reports wider loss By Investing.com - Investing.com UK
Entera Bio misses Q2 estimates, reports wider loss - Investing.com
Entera Bio Ltd. (ENTX) stock price, news, quote and history - au.finance.yahoo.com
Entera Bio (NASDAQ:ENTX) Upgraded to Sell at Wall Street Zen - MarketBeat
Entera Bio raises $275M in oversubscribed placement, shares rebound on funding news - scanx.trade
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):